RSSCategory: Reports

Is the Pen Mightier Than the Scalpel?

| September 13, 2017 | 0 Comments

Although a surgeon’s goal is to remove cancer in its entirety during excision surgery, achieving negative margins (absence of cancer cells at the outer edge of the excised tumor specimen) can be challenging. To facilitate intraoperative diagnosis, Zhang et al. from multiple institutions in Texas developed a handheld pen-like device that rapidly identifies the molecular profile of […]

Continue Reading

Pathology and Our Societies Need to Evolve

| September 4, 2017 | 0 Comments

Over the past 20+ years I have had the good fortune of attending dozens of national meetings hosted by organizations and societies outside of the pathology field. Going to medical school in Chicago offered medical students in the city the opportunity to attend large gynecology, pediatric, surgery and internal medicine meetings, not to mention their […]

Continue Reading

Corista to Host Seminar on Digital Pathology and the Emerging Role of Artificial Intelligence

| July 23, 2017 | 0 Comments

Alexander Baras, M.D., Ph.D. of Johns Hopkins to join company experts at APC presentation Corista, a leader in integrated pathology solutions, is hosting a multi-part seminar on digital pathology and artificial intelligence Tuesday, July 25, during the Association of Pathology Chairs’ Jubilee Meeting in Washington, DC. The seminar features Dr. Alexander Baras from Johns Hopkins […]

Continue Reading

Will Robot Surgeons Provide Better Clinical Histories?

| July 7, 2017 | 0 Comments

Berci Mesko, MD, PhD, The Medical Futurist, a self-proclaimed “geek physician with a PhD in genomics and Amazon Top 100 author” who envisions “the impact of digital health technologies on the future of healthcare, and helps patients, doctors, government regulators and companies make it a reality” recently shared this infographic on Twitter. Berci has a lot […]

Continue Reading

Digital Pathology Association Session to Take Place at 29th European Congress of Pathology

| July 5, 2017 | 0 Comments

SAVE THE DATE! DIGITAL PATHOLOGY ASSOCIATION SESSION To take place at the 29th European Congress of Pathology Sunday, September 3, 2017 | 2:45-5:15 PM Amsterdam, The Netherlands Presentations Include: Computational Pathology and Interoperability to advance Digital Pathology Esther Abels, MSc Philips Digital Pathology Solutions   Automated IA of Immunohistochemistry as a Biomarker for Immuno-oncology Michael Montalto, PhD Bristol-Myers Squibb […]

Continue Reading

VisionGate Hires Dr. David Wilbur as Medical Director

| June 9, 2017 | 0 Comments

VisionGate, Inc. recently announced the appointment of Dr. David Wilbur as Medical Director of its Phoenix-based CLIA laboratory, VisionGate Biosignatures Laboratory (VBL). A world-renowned pathologist, Dr. Wilbur comes to VisionGate from Massachusetts General Hospital (MGH), where he has been a practicing pathologist since 2001. He headed the Cytopathology Unit until 2011, when he took over the […]

Continue Reading

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary surgical pathology diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

Visiopharm Engages in Major Initiative for Deep Learning in Tissue Based Pathology

Hørsholm, Denmark, May 3rd – Visiopharm A/S announces the first result of their multifaceted strategy to apply Deep Learning technologies to its leading image analysis solution for cancer research and diagnostics. Visiopharm considers Deep Learning an important technological breakthrough for tissue pathology that offers the potential to make a real difference in the assessment of […]

Continue Reading

German Shepherds to Replace Mammograms

| March 26, 2017 | 0 Comments

Last week a loyal reader sent me a link to an article on Yahoo! that headlined “Dogs detect breast cancer from bandage: researchers” from a French news agency. The article goes on to report that specially trained German Shepherds could successfully detect breast cancer 100% of the time, being able to “recognise cancerous rags from […]

Continue Reading

“Academic” Tweeting – Is it “Academic” and Will it Be Recognized as Such?

| March 23, 2017 | 2 Comments

Dr. Bruce Friedman over at Lab Soft News has an interesting post today on “The “Why” and “How” of Academic Tweeting”. Many of you know that Bruce is widely considered the grandfather of pathology informatics, coining the term decades ago, envisioning organizations, societies, fellowships before many. He and Mike Becich are two people I would […]

Continue Reading

Visiopharm Announces Inaugural North America User Group Meeting

| March 9, 2017 | 0 Comments

Visiopharm is proud to announce our inaugural North America User Group Meeting, in collaboration with Pathology Informatics Summit, May 20th – May 21st 2017. The meeting will begin with a fun filled customer appreciation night, watching the Pirates at PNC Park from a World Series Suite, followed by a full day of scientific presentations and […]

Continue Reading

Tweeting Pathologists: How #InSituPathologists Changed the Way Pathologists Communicate

| January 25, 2017 | 0 Comments

A paper was recently published in Modern Pathology (ePub ahead of print) entitled “#InSituPathologists: how the #USCAP2015 meeting went viral on Twitter and founded the social media movement for the United States and Canadian Academy of Pathology that details the activity of “live tweeting” the USCAP 2015 and USCAP 2016 and how it all got […]

Continue Reading

Epigenetics Changes Promote Pancreatic Cancer Metastasis

| January 20, 2017 | 0 Comments

Courtesy of Clinical OMICs – Molecular Diagnostics in Personalized Medicine Johns Hopkins researchers have published new data that suggests epigenetic changes controlling how DNA operates, provides survival advantages to a subset of pancreatic cancer cells. The results, published in the Nature Genetics article, “Epigenomic Reprogramming during Pancreatic Cancer Progression Links Anabolic Glucose Metabolism to Distant Metastasis,” […]

Continue Reading